Enhanced anticancer potency of doxorubicin in combination with curcumin in gastric adenocarcinoma

Enhanced anticancer potency of doxorubicin in combination with curcumin in gastric adenocarcinoma


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: الهام طاهری اصغری , صبا حاج عظیمیان , علیرضا عیسی زاده , داریوش شانه بندی

کلمات کلیدی: combination therapy, curcumin, doxorubicin, gastric cancer

نشریه: 19477 , 6 , 34 , 2020

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله داریوش شانه بندی
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه مرکز تحقیقات ایمونولوژی
کد مقاله 71393
عنوان فارسی مقاله Enhanced anticancer potency of doxorubicin in combination with curcumin in gastric adenocarcinoma
عنوان لاتین مقاله Enhanced anticancer potency of doxorubicin in combination with curcumin in gastric adenocarcinoma
ناشر 9
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ بلی
عنوان نشریه (خارج از لیست فوق)
نوع مقاله Original Article
نحوه ایندکس شدن مقاله ایندکس شده سطح یک – ISI - Web of Science
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

Gastric cancer (GC) is one of the prevalent human malignancies and the third most common cause of cancer‐related death worldwide. The doxorubicin hydrochloride is one of the important chemotherapeutic anticancer agents, with a limited therapeutic efficacy for treatment of GC. Therefore, taking advantage of synergistic effects by strategies like combination therapy seems appropriate and promising in treatment of GC. The aim of this study was to investigate a novel method to enhance the therapeutic efficacy of doxorubicin (as a chemotherapeutic agent) by co‐administration of curcumin (as a bioactive herbal compound) in GC treatment. In the present study, the effects of curcumin, doxorubicin, and their combinations (Dox‐Cur) were evaluated on the viability, morphological features, tumor spheroid formation, migration, invasion, and apoptosis of gastric adenocarcinoma cell line (AGS). Moreover, expression levels of BAX, BCL‐2, and CASP9 genes were assessed among AGS cells treated with curcumin, doxorubicin, and Dox‐Cur. The obtained results showed that all of curcumin, doxorubicin, and Dox‐Cur treatments significantly decreased the viability, tumor spheroid formation, migration, and invasion in the GC model cells. Furthermore, apoptosis rates in AGS cells were increased in a concentration‐ and time‐dependent manner in all of the treatment groups. Moreover, the anticancer activity of the Dox‐Cur combination was significantly more than curcumin and doxorubicin treatments alone. According to the results, Dox‐Cur combination therapy exerts more profound apoptotic and anticancer effects on the AGS cell line than curcumin or doxorubicin monotherapy.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
الهام طاهری اصغریسوم
صبا حاج عظیمیانهفتم
علیرضا عیسی زادههشتم
داریوش شانه بندینهم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
Enhanced anticancer potency of doxorubicin in combination with curcumin in.pdf1398/12/172231432دانلود